Transgene Biotek Limited reported earnings results for the second quarter ended September 30, 2023. For the second quarter, the company reported sales was INR 0.45 million. Revenue was INR 0.88847 million compared to INR 0.43847 million a year ago.

Net loss was INR 1.33 million compared to INR 17.7 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.23 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.23 a year ago.